Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.36 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.35 |
| ▸ | SLC9A1 | P19634 | 2/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | ACP1 | P24666 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 4/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.32 |
| ▸ | IDO1 | P14902 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20172868 | 0.88 | GPR3 (0.38) | GPR3PARP14ALOX5MAPTKIF11 | |
| SCHEMBL20172922 | 0.88 | ACP1 (0.35) | ACP1KIF11CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL20172912 | 0.87 | ACP1 (0.33) | ACP1KIF11CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL20733887 | 0.86 | GPR3 (0.48) | GPR3PARP14ALOX5MAPTCLK4 | |
| SCHEMBL20172918 | 0.84 | HDAC3 (0.33) | ACP1KIF11CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL20172880 | 0.84 | ACP1 (0.33) | ACP1MAPTKIF11CYP1A2CYP2D6 | |
| SCHEMBL20172890 | 0.84 | ACP1 (0.33) | ACP1KIF11CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL21021048 | 0.81 | P2RX7 (0.35) | ACP1KIF11CYP2C9IDO1HDAC6 | |
| SCHEMBL21021486 | 0.81 | POLQ (0.36) | ACP1CYP1A2CYP2D6HDAC6KDM4E | |
| SCHEMBL20172940 | 0.81 | ACP1 (0.34) | ACP1KIF11CYP1A2CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10651411-B2 | Compound and organic light emitting device containing same | LG CHEM, LTD. (KR) | 2020-05-12 | — | — | US | disclosed |
| US-20190152919-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2019-05-23 | — | — | US | disclosed |
| EP-3428152-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG Chem, Ltd. (KR) | 2019-01-16 | — | — | EP | disclosed |
| US-20180145272-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CONTAINING SAME | LG CHEM, LTD. (KR) | 2018-05-24 | — | — | US | disclosed |
| US-20180145272-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CONTAINING SAME | LG CHEM, LTD. (KR) | 2018-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180145272-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CONTAINING SAME | CRY1, CRY2, OR10J3 | GPR3 2049/4885PARP14 3288/4885SLC9A1 4772/4885 |
| US-20190152919-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | OR10J3, ETV6, ESR1 | GPR3 4628/4885PARP14 4124/4885SLC9A1 1463/4885 |
| US-10651411-B2 | Compound and organic light emitting device containing same | CRY1, CRY2, OR10J3 | GPR3 2049/4885PARP14 3288/4885SLC9A1 4772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.